Achieve Life Sciences, Inc. Share Price
NASDAQ: ACHV$0.00
+0.00 (0.00%) Achieve Life Sciences, Inc. Stock Performance
Achieve Life Sciences, Inc. Share Price Chart
$0.00$0.00
L
H
Achieve Life Sciences, Inc. Quarterly Profit & Loss
All figures in USD
Achieve Life Sciences, Inc. Annual Profit & Loss
All figures in USD
About Achieve Life Sciences, Inc.
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.
Achieve Life Sciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|